NCT05164029

Brief Summary

The study will conduct a multicenter prospective clinical cohort study to collect comprehensive health information and essential specimens from pre-pregnancy to postpartum offspring development. We will combine the reproductive medicine with the big data technologies and cloud computing to explore the key factors which will induce the occurrence the reproductive disorders and effect the health of women and offspring. Based on the discovery of the cohort study, we will construct a prediction model for improvement of ART,optimizing the effectiveness and safety of ART.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2022

Typical duration for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 9, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 20, 2021

Completed
12 days until next milestone

Study Start

First participant enrolled

January 1, 2022

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

December 20, 2021

Status Verified

December 1, 2021

Enrollment Period

2.4 years

First QC Date

December 9, 2021

Last Update Submit

December 17, 2021

Conditions

Outcome Measures

Primary Outcomes (5)

  • live birth rate

    Number of women with live births / number of women randomized to the specific group.

    1 day after delivery

  • birth weight

    Weight of newborns at delivery.

    1 day after delivery

  • weight

    the weight of offspring

    Change from the date of delivery up to 2 years after delivery

  • height

    the height of offspring

    Change from the date of delivery up to 2 years after delivery

  • Incidence of mental diseases and metabolic dysfunction

    from the date of delivery up to 2 years after delivery

Secondary Outcomes (4)

  • implantation rate

    11-12 weeks after embryo transfer

  • clinical pregnancy rate

    6 weeks after embryo transfer

  • preterm birth rate

    28 gestational weeks to 37 gestational weeks

  • neonatal complication rate

    1 day after delivery

Study Arms (2)

ART couples

Couples in reproductive age undergoing ART treatment

Other: Completion questionnaires/providing biological samples

natural pregnancy couples

Couples who get pregnant naturally

Other: Completion questionnaires/providing biological samples

Interventions

Participant completes baseline interview at enrollment, then completes questionnaires and provides biological samples at each scheduled study visit.

ART couplesnatural pregnancy couples

Eligibility Criteria

Age20 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Study subjects will be recruited from couples seeking treatment of infertility or getting pregnant naturally and wanting to deliver their babies in the study hospitals. Men must be at least 22 years old and women must be at least 20 years to participate in the study.

You may qualify if:

  • Couples undergoing treatment for infertility or getting pregnant naturally and wanting to deliver their babies in study hospitals.
  • Men 22-55 years old
  • Women 20 - 45 years old

You may not qualify if:

  • Any individual or couple who is outside of age range .
  • Any couple who don't plan to complete their pregnancy check-up or deliver their babies in study hospitals.
  • Any couples had participated in other clinical studies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Dan Zhang, M.D, Ph.D

CONTACT

Ruixue Chen, M.D, Ph.D

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice president

Study Record Dates

First Submitted

December 9, 2021

First Posted

December 20, 2021

Study Start

January 1, 2022

Primary Completion

June 1, 2024

Study Completion

December 1, 2024

Last Updated

December 20, 2021

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share

All data relevant to the study will be generated in the article or uploaded as supplementary information. Deidentified participant data will be available from Dr. Dan Zhang (zhangdan@zju.edu.cn) on a reasonable request. Protocols and statistical analysis plans will be included as supplementary information.